Hydrogen-rich water supplementation attenuates oxidative stress and inflammation in chronic high-altitude disease patients: A double-blind randomized placebo-controlled study.
In with CHAD were recruited and assigned to the HRW or placebo water (PW) group for 60 days, these results suggest the potential protective role of HRW in CHAD, providing a novel adjuvant therapy for CHAD. These findings add human evidence supporting…
Read Article